Natera, Inc. clinical trials
The registry lists 36 studies whose lead sponsor is Natera, Inc.. 11 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 5, 2026.
Our grouping of 1 registry name, not the registry’s. See them and correct one ↓
- 36studies on the registry
- 11open to participants now
- 3reach primary completion within a year
Get an email when these change. Save the Natera, Inc. studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
What it is testing
The drugs Natera, Inc.’s studies test, most open studies first — 2 drugs with a page of their own. Each count opens the studies in search.
Open now Not open: under way, finished or stopped
Coming up
3 of Natera, Inc.’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.
Phase 3 Other phases
- NNov ’26’26
- DDec
- JJan ’27’27
- 1FFeb
- MMar
- 1AApr
- MMay
- JJun
- 1JJul
- AAug
- SSep
- OOct
- NNov
All 3
- Feb 2027A Comparative Effectiveness Study in Heart Transplant Patients of Rejection Surveillance With Cell-free DNA Versus Endomyocardial BiopsyNCT06414603
- Apr 2027EXpanding Prenatal Cell Free DNA Screening Across moNogenic Disorders (EXPAND)NCT06808880
- Jul 2027Evaluation of the Natera Colorectal Cancer Screening Test in an Average Risk Population (FIND-CRC)NCT07046585
Add all 3 to your calendar (.ics) → With an account.
All 36 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
Over the years
- 09
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 626
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Natera, Inc..
- Natera, Inc.36 studiesSame company
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 36 of 36.
- Signatera-Guided CDK4/6 Inhibitor Therapy in Breast CancerRecruitingNCT07214532Not applicable
- A Multicenter Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.Not yet recruitingNCT07689812Not applicable
- Sample Collection for Ongoing Research and Product Evaluation Study - Non-muscle Invasive Bladder Cancer (SCORE-NMIBC)RecruitingNCT07763197
- Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL)RecruitingNCT07750886
- Immunosuppression Optimization Using The Prospera Assay In Kidney Transplant Recipients (IMPAKT)Not yet recruitingNCT07718633Not applicable
- Signatera Assessment in Early-Stage Endometrial CancerNot yet recruitingNCT07339384Not applicable
- EXpanding Prenatal Cell Free DNA Screening Across moNogenic Disorders (EXPAND)RecruitingNCT06808880
- Signatera-Guided De-escalation of Adjuvant Therapy in Resectable Stage II-IVa Gastric/Gastric-Esophageal CancerNot yet recruitingNCT07565857Not applicable
- Sample Collection for Ongoing Research and Product Evaluation StudyRecruitingNCT07318051
- Evaluation of the Natera Colorectal Cancer Screening Test in an Average Risk Population (FIND-CRC)RecruitingNCT07046585
- Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer DetectionRecruitingNCT06620627
- Verification of Risk Assignment for Whole Chromosome Using SNP-based NIPT in Vanishing Twin PregnanciesCompletedNCT05004337
- A Comparative Effectiveness Study in Heart Transplant Patients of Rejection Surveillance With Cell-free DNA Versus Endomyocardial BiopsyActive, not recruitingNCT06414603Not applicable
- LAMBDA 002 (Lung Registry) StudyActive, not recruitingNCT05170425
- Prospera Test Evaluation in Cardiac Transplant (ProTECT)Active, not recruitingNCT05205551
- Study for the Prediction of Active Rejection in Organs Using Donor-derived Cell-free DNA DetectionCompletedNCT03984747
- Development of Non-invasive Cell-free DNA to Supplant Invasive Biopsy in Heart TransplantationCompletedNCT05309382
- Clinical Utility of the Addition of a SNP-based NIPT Zygosity Determination in Twin Pregnancy Management.CompletedNCT05312814
- BESPOKE Study of ctDNA Guided ImmunotherapyCompletedNCT04761783
- The PROspera Kidney Transplant ACTIVE Rejection Assessment Registry (ProActive)Active, not recruitingNCT04091984
- Donor-Derived Cell-free DNA to DETect REjection in Cardiac TransplantationWithdrawnNCT05081739Not applicable
- BESPOKE Study of ctDNA Guided Therapy in Colorectal CancerActive, not recruitingNCT04264702
- Renasight Clinical Application, Review and Evaluation (RenaCARE) StudyActive, not recruitingNCT05846113Not applicable
- Prenatal Non-invasive Aneuploidy Test Utilizing SNPs TrialTerminatedNCT01545674
- SNP-based Microdeletion and Aneuploidy RegisTry (SMART)CompletedNCT02381457
- Development of Non-invasive Prenatal Screening Test for Microdeletions Based on Fetal DNA Isolated From Maternal BloodCompletedNCT01852708
- Natera Ovarian Cancer Detection AssayTerminatedNCT03485651
- Multiple Gestation StudyCompletedNCT02278536
- Development of Non-invasive Prenatal Test for Microdeletion and Other Genetic Syndromes Based on Cell Free DNACompletedNCT02109770
- High Risk Multiple Gestation StudyCompletedNCT02278874
- Impact of Parental Support on Pregnancy Outcomes (IPSO) Trial- Day 3 Preimplantation Genetic Screening (PGS) With Day 5 Fresh TransferTerminatedNCT01194531Phase 4
- Concurrent Single Gene and 24 Chromosome Aneuploidy Preimplantation Genetic Diagnosis (PGD)CompletedNCT01023048Not applicable
- Collection of Maternal Blood Samples for Development of Non-invasive Prenatal Diagnostic TestingCompletedNCT01546324
- Clinical Use of Parental Support To Detect Single Gene MutationsCompletedNCT01197872
- Multi-disease Carrier Screening Test ValidationWithdrawnNCT01663584
- Non-invasive Prenatal Diagnostic Validation StudyCompletedNCT01574781